Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Charpentier

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2016
Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 TrialAnne-Marie Charpentier, Debra L Friedman, Suzanne Wolden, et al.
Practical Radiation Oncology|April 29, 2014
Active breathing control for patients receiving mediastinal radiation therapy for lymphoma: Impact on normal tissue doseAnne-Marie Charpentier, Tatiana Conrad, Jenna Sykes, et al.
International Journal of Radiation Oncology, Biology, Physics|September 3, 2022
Risk of Cerebrovascular Events Among Childhood and Adolescent Patients Receiving Cranial Radiation Therapy: A PENTEC Normal Tissue Outcomes Comprehensive ReviewJonathan F Waxer, Kenneth Wong, Arezoo Modiri, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2025
Multimodality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin LymphomaXin Tie, Sarah A Milgrom, Andrea C Lo, et al.
The New England Journal of Medicine|November 2, 2022
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's LymphomaSharon M Castellino, Qinglin Pei, Susan K Parsons, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2026
Subsequent Neoplasm Risk after Modern Mediastinal Radiotherapy for Pediatric Hodgkin Lymphoma: Insights from a Multi-Institutional Children's Oncology Group TrialSarah A Milgrom, Harald Paganetti, Hitesh Dama, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2023
Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation TherapyBradford S Hoppe, Kathleen M McCarten, Qinglin Pei, et al.
International Journal of Radiation Oncology, Biology, Physics|June 30, 2025
Comparison of Contemporary Radiation Therapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331Bradford S Hoppe, Raymond B Mailhot-Vega, Lindsay A Renfro, et al.
Ecology Letters|May 1, 2008
Senescence rates are determined by ranking on the fast-slow life-history continuumOwen R Jones, Jean-Michel Gaillard, Shripad Tuljapurkar, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2016
Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 TrialAnne-Marie Charpentier, Debra L Friedman, Suzanne Wolden, et al.
Practical Radiation Oncology|April 29, 2014
Active breathing control for patients receiving mediastinal radiation therapy for lymphoma: Impact on normal tissue doseAnne-Marie Charpentier, Tatiana Conrad, Jenna Sykes, et al.
International Journal of Radiation Oncology, Biology, Physics|September 3, 2022
Risk of Cerebrovascular Events Among Childhood and Adolescent Patients Receiving Cranial Radiation Therapy: A PENTEC Normal Tissue Outcomes Comprehensive ReviewJonathan F Waxer, Kenneth Wong, Arezoo Modiri, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2025
Multimodality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin LymphomaXin Tie, Sarah A Milgrom, Andrea C Lo, et al.
The New England Journal of Medicine|November 2, 2022
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's LymphomaSharon M Castellino, Qinglin Pei, Susan K Parsons, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2026
Subsequent Neoplasm Risk after Modern Mediastinal Radiotherapy for Pediatric Hodgkin Lymphoma: Insights from a Multi-Institutional Children's Oncology Group TrialSarah A Milgrom, Harald Paganetti, Hitesh Dama, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2023
Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation TherapyBradford S Hoppe, Kathleen M McCarten, Qinglin Pei, et al.
International Journal of Radiation Oncology, Biology, Physics|June 30, 2025
Comparison of Contemporary Radiation Therapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331Bradford S Hoppe, Raymond B Mailhot-Vega, Lindsay A Renfro, et al.
Ecology Letters|May 1, 2008
Senescence rates are determined by ranking on the fast-slow life-history continuumOwen R Jones, Jean-Michel Gaillard, Shripad Tuljapurkar, et al.
Pageof 2